| 000 | 01900 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517040043.0 | ||
| 264 | 0 | _c20160926 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1936-2625 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSekiguchi, Yasunobu | |
| 245 | 0 | 0 |
_aPeripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature. _h[electronic resource] |
| 260 |
_bInternational journal of clinical and experimental pathology _c2015 |
||
| 300 |
_a4186-203 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 | _aBone Marrow Examination |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 |
_aCytokines _xblood |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aLymph Nodes _xdrug effects |
| 650 | 0 | 4 |
_aLymphoma, T-Cell, Peripheral _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
| 650 | 0 | 4 |
_aPrimary Myelofibrosis _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 700 | 1 | _aShirane, Syuichi | |
| 700 | 1 | _aShimada, Asami | |
| 700 | 1 | _aIchikawa, Kunimoto | |
| 700 | 1 | _aWakabayashi, Mutsumi | |
| 700 | 1 | _aSugimoto, Keiji | |
| 700 | 1 | _aTomita, Shigeki | |
| 700 | 1 | _aIzumi, Hiroshi | |
| 700 | 1 | _aNakamura, Noriko | |
| 700 | 1 | _aSawada, Tomohiro | |
| 700 | 1 | _aOhta, Yasunori | |
| 700 | 1 | _aKomatsu, Norio | |
| 700 | 1 | _aNoguchi, Masaaki | |
| 773 | 0 |
_tInternational journal of clinical and experimental pathology _gvol. 8 _gno. 4 _gp. 4186-203 |
|
| 999 |
_c25004385 _d25004385 |
||